- Home
- PHGE vs AREB Comparison
PHGE vs AREB Comparison
Compare PHGE & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- AREB
- Stock Information
- Founded
- PHGE 2015
- AREB 2014
- Country
- PHGE Israel
- AREB United States
- Employees
- PHGE N/A
- AREB N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- AREB Plastic Products
- Sector
- PHGE Health Care
- AREB Industrials
- Exchange
- PHGE Nasdaq
- AREB Nasdaq
- Market Cap
- PHGE 10.4M
- AREB 8.4M
- IPO Year
- PHGE N/A
- AREB N/A
- Fundamental
- Price
- PHGE $0.52
- AREB $0.69
- Analyst Decision
- PHGE Strong Buy
- AREB
- Analyst Count
- PHGE 1
- AREB 0
- Target Price
- PHGE $15.00
- AREB N/A
- AVG Volume (30 Days)
- PHGE 991.6K
- AREB 382.3K
- Earning Date
- PHGE 08-13-2025
- AREB 08-12-2025
- Dividend Yield
- PHGE N/A
- AREB N/A
- EPS Growth
- PHGE N/A
- AREB N/A
- EPS
- PHGE N/A
- AREB N/A
- Revenue
- PHGE N/A
- AREB $9,474,958.00
- Revenue This Year
- PHGE N/A
- AREB N/A
- Revenue Next Year
- PHGE N/A
- AREB N/A
- P/E Ratio
- PHGE N/A
- AREB N/A
- Revenue Growth
- PHGE N/A
- AREB N/A
- 52 Week Low
- PHGE $0.34
- AREB $0.68
- 52 Week High
- PHGE $1.23
- AREB $193.48
- Technical
- Relative Strength Index (RSI)
- PHGE 50.56
- AREB 21.23
- Support Level
- PHGE $0.49
- AREB $0.70
- Resistance Level
- PHGE $0.56
- AREB $0.89
- Average True Range (ATR)
- PHGE 0.04
- AREB 0.11
- MACD
- PHGE -0.01
- AREB -0.04
- Stochastic Oscillator
- PHGE 49.28
- AREB 1.25
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.